Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Oncology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Cancer/Tumors Clinical Trials

A listing of Cancer/Tumors medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (7680) clinical trials

People with renal cell carcinoma are asked to participate in a research study being conducted by North Shore University Hospital.  

Phase N/A

People with pancreatic cancer are asked to participate in a research study being conducted by Northwell Health.  

Phase N/A

People with prostate cancer  and cardiovascular Disease are asked to participate in a research study being conducted by Montefiore Medical Center.  

Phase N/A

1.1 Phase 1 Primary To evaluate the safety and tolerability of RX-3117 in combination with Abraxane® in subjects with metastatic pancreatic cancer To determine the Recommended Phase 2 Dose (RP2D) of RX-3117 when administered orally in combination with Abraxane® to subjects with metastatic pancreatic cancer 1.2 Phase 1 Secondary To ...

Phase

A research study is evaluating an investigational treatment for chemotherapy induced peripheral neuropathy in patients with colorectal cancer (CRC).

Phase N/A

The purpose of this study is to determine the safety, preliminary evidence of clinical activity, and recommended Phase 2 dose (RP2D) of INCMGA00012 in combination with other agents that may improve the therapeutic efficacy of anti-PD-1 monotherapy.

Phase

The purpose of this study is to assess the clinical activity and safety of INCMGA00012 in participants with metastatic merkel cell carcinoma (MCC).  

Phase

People with Cholangiocarcinoma are asked to participate in a research study being conducted by White Plains Hospital.

Phase N/A

Evaluates the safety, tolerability, pharmacokinetics, metabolites, pharmacodynamics, and clinical activity of MRTX849 in patients with advanced solid tumors with a KRAS G12C mutation. MRTX849 is an orally-available small molecule inhibitor of KRAS G12C.

Phase